Literature DB >> 26748890

Structure-Based Development of an Affinity Probe for Sirtuin 2.

Matthias Schiedel1, Tobias Rumpf1, Berin Karaman2, Attila Lehotzky3, Stefan Gerhardt4, Judit Ovádi3, Wolfgang Sippl2, Oliver Einsle4, Manfred Jung5.   

Abstract

Sirtuins are NAD(+)-dependent protein deacylases that cleave off acetyl groups, as well as other acyl groups, from the ɛ-amino group of lysines in histones and other substrate proteins. Dysregulation of human Sirt2 activity has been associated with the pathogenesis of cancer, inflammation, and neurodegeneration, thus making Sirt2 a promising target for pharmaceutical intervention. Here, based on a crystal structure of Sirt2 in complex with an optimized sirtuin rearranging ligand (SirReal) that shows improved potency, water solubility, and cellular efficacy, we present the development of the first Sirt2-selective affinity probe. A slow dissociation of the probe/enzyme complex offers new applications for SirReals, such as biophysical characterization, fragment-based screening, and affinity pull-down assays. This possibility makes the SirReal probe an important tool for studying sirtuin biology.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  deacylases; drug design; protein modifications; proteomics; sirtuins

Mesh:

Substances:

Year:  2016        PMID: 26748890     DOI: 10.1002/anie.201509843

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  15 in total

Review 1.  Cellular analysis of the action of epigenetic drugs and probes.

Authors:  Mirjam Hau; Fides Zenk; A Ganesan; Nicola Iovino; Manfred Jung
Journal:  Epigenetics       Date:  2017-01-10       Impact factor: 4.528

2.  Identification of a novel small molecule that inhibits deacetylase but not defatty-acylase reaction catalysed by SIRT2.

Authors:  Norio Kudo; Akihiro Ito; Mayumi Arata; Akiko Nakata; Minoru Yoshida
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-06-05       Impact factor: 6.237

3.  New chemical tools for probing activity and inhibition of the NAD+-dependent lysine deacylase sirtuin 2.

Authors:  Sören Swyter; Matthias Schiedel; Daria Monaldi; Sándor Szunyogh; Attila Lehotzky; Tobias Rumpf; Judit Ovádi; Wolfgang Sippl; Manfred Jung
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-06-05       Impact factor: 6.237

Review 4.  Sirtuin modulators: past, present, and future perspectives.

Authors:  Francesco Fiorentino; Nicola Mautone; Martina Menna; Francesca D'Acunzo; Antonello Mai; Dante Rotili
Journal:  Future Med Chem       Date:  2022-05-18       Impact factor: 4.767

Review 5.  Studying epigenetic complexes and their inhibitors with the proteomics toolbox.

Authors:  David Weigt; Carsten Hopf; Guillaume Médard
Journal:  Clin Epigenetics       Date:  2016-07-18       Impact factor: 6.551

6.  Identification of Bichalcones as Sirtuin Inhibitors by Virtual Screening and In Vitro Testing.

Authors:  Berin Karaman; Zayan Alhalabi; Sören Swyter; Shetonde O Mihigo; Kerstin Andrae-Marobela; Manfred Jung; Wolfgang Sippl; Fidele Ntie-Kang
Journal:  Molecules       Date:  2018-02-14       Impact factor: 4.411

7.  Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket.

Authors:  Sandeep Sundriyal; Sébastien Moniot; Zimam Mahmud; Shang Yao; Paolo Di Fruscia; Christopher R Reynolds; David T Dexter; Michael J E Sternberg; Eric W-F Lam; Clemens Steegborn; Matthew J Fuchter
Journal:  J Med Chem       Date:  2017-02-15       Impact factor: 7.446

8.  An Activity-Based Probe Targeting Non-Catalytic, Highly Conserved Amino Acid Residues within Bromodomains.

Authors:  Melissa D'Ascenzio; Kathryn M Pugh; Rebecca Konietzny; Georgina Berridge; Cynthia Tallant; Shaima Hashem; Octovia Monteiro; Jason R Thomas; Markus Schirle; Stefan Knapp; Brian Marsden; Oleg Fedorov; Chas Bountra; Benedikt M Kessler; Paul E Brennan
Journal:  Angew Chem Int Ed Engl       Date:  2018-12-27       Impact factor: 15.336

9.  Modulation Of Microtubule Acetylation By The Interplay Of TPPP/p25, SIRT2 And New Anticancer Agents With Anti-SIRT2 Potency.

Authors:  Adél Szabó; Judit Oláh; Sándor Szunyogh; Attila Lehotzky; Tibor Szénási; Marianna Csaplár; Matthias Schiedel; Péter Lőw; Manfred Jung; Judit Ovádi
Journal:  Sci Rep       Date:  2017-12-06       Impact factor: 4.379

10.  Potent mechanism-based sirtuin-2-selective inhibition by an in situ-generated occupant of the substrate-binding site, "selectivity pocket" and NAD+-binding site.

Authors:  Paolo Mellini; Yukihiro Itoh; Hiroki Tsumoto; Ying Li; Miki Suzuki; Natsuko Tokuda; Taeko Kakizawa; Yuri Miura; Jun Takeuchi; Maija Lahtela-Kakkonen; Takayoshi Suzuki
Journal:  Chem Sci       Date:  2017-07-21       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.